HA Burris, S Bakewell, JC Bendell,
J Infante, SF Jones… - ESMO open, 2016 - Elsevier
Objective This phase I clinical study (NCT01415297) evaluated the safety, tolerability,
maximum-tolerated dose (MTD), pharmacokinetics and pharmacodynamics of IT-139 …